A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck

This study was designed to evaluate the activity, safety and tolerance of docetaxel (D) in a selected population with metastatic squamous cell carcinoma of the head and neck (SCCHN). Twenty-four patients with no prior palliative therapy were enrolled and received D 100 mg m(−2) by 1 h of infusion, e...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Couteau, C, Chouaki, N, Leyvraz, S, Oulid-Aissa, D, Lebecq, A, Domenge, C, Groult, V, Bordessoule, S, Janot, F, Forni, M De, Armand, J-P
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 1999
Sujets:
Regular Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2362927/
https://ncbi.nlm.nih.gov/pubmed/10507770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690715
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires